PF-Atlas › Clinical Trials › NCT03516331

A Drug-Drug Interaction Study of FDL169 and FDL176 in Healthy Subjects

FDL176 & FDL169 coadministration · Phase 1

Registry ID
NCT03516331
Phase
Phase 1
Status
Completed
Drug / intervention
FDL176 & FDL169 coadministration
Sponsor
Flatley Discovery Lab LLC
Start
2018-03-07
Enrollment
16
Locations
1

About this trial

This is an 2-part study. Part 1 will assess the safety, tolerability and pharmacokinetics of single doses of FDL176 with and without co-administration of FDL169. Part 2 will assess the safety, tolerability and pharmacokinetics of repeated doses of FDL176 with and without co-administration of FDL169 .

View NCT03516331 on ClinicalTrials.gov →

Explore related

All FDL176 & FDL169 coadministration trialsAll IPF trials
Medical disclaimer. This page summarizes public trial data for NCT03516331 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.